Dermavant Presents New Patient Satisfaction Data from PSOARING 3 Long Term Extension Trial of Tapinarof in Adults with Plaque Psoriasis at the 2022 Winter Clinical Dermatology Conference

LONG BEACH, Calif. & BASEL, Switzerland--(BUSINESS WIRE)--Dermavant Presents New Patient Satisfaction Data from PSOARING 3 Long Term Extension Trial of Tapinarof in Plaque Psoriasis at 2022 Winter Clinical

Click to view original post